Author: Arghiani, Nahid; Nissan, Tracy; Matin, Maryam M.
Title: Role of microRNAs in COVID-19 with implications for therapeutics Cord-id: ilp3549f Document date: 2021_9_25
ID: ilp3549f
Snippet: COVID-19 is a pneumonia-like disease with highly transmittable and pathogenic properties caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which infects both animals and humans. Although many efforts are currently underway to test possible therapies, there is no specific FDA approved drug against SARS-CoV-2 yet. miRNA-directed gene regulation controls the majority of biological processes. In addition, the development and progression of several human diseases are associated
Document: COVID-19 is a pneumonia-like disease with highly transmittable and pathogenic properties caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which infects both animals and humans. Although many efforts are currently underway to test possible therapies, there is no specific FDA approved drug against SARS-CoV-2 yet. miRNA-directed gene regulation controls the majority of biological processes. In addition, the development and progression of several human diseases are associated with dysregulation of miRNAs. In this regard, it has been shown that changes in miRNAs are linked to severity of COVID-19 especially in patients with respiratory diseases, diabetes, heart failure or kidney problems. Therefore, targeting these small noncoding-RNAs could potentially alleviate complications from COVID-19. Here, we will review the roles and importance of host and RNA virus encoded miRNAs in COVID-19 pathogenicity and immune response. Then, we focus on potential miRNA therapeutics in the patients who are at increased risk for severe disease.
Search related documents:
Co phrase search for related documents- adaptive immune system and lung cancer: 1
- adaptive immune system and lung disease: 1, 2
- adaptive immune system and lung infection: 1, 2, 3, 4
- adaptive immune system and lung inflammation: 1, 2, 3, 4
- adaptive immune system and lung tissue: 1, 2, 3
- adaptive immunity and lung cancer: 1, 2, 3, 4
- adaptive immunity and lung disease: 1, 2, 3, 4, 5, 6, 7, 8
- adaptive immunity and lung dysfunction: 1
- adaptive immunity and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- adaptive immunity and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- adaptive immunity and lung tissue: 1, 2, 3, 4, 5, 6, 7
- adaptive innate and low grade fever: 1
- adaptive innate and lung cancer: 1, 2, 3, 4, 5, 6, 7
- adaptive innate and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- adaptive innate and lung dysfunction: 1, 2, 3, 4
- adaptive innate and lung epithelial cell: 1, 2, 3
- adaptive innate and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31
- adaptive innate and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- lung inflammation and macrophage cytoplasm: 1
Co phrase search for related documents, hyperlinks ordered by date